安进Amgen（AMGN）2024年10-K年度报告「NASDAQ」（英文版）（326页）.pdf

1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549Form 10-K(Mark One)ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGEACT OF 1934For the fiscal year ended December 31,2024orTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIESEXCHANGE ACT OF 1934Co

2、mmission file number 001-37702Amgen Inc.(Exact name of registrant as specified in its charter)Delaware95-3540776(State or other jurisdiction of incorporation or organization)(I.R.S.Employer Identification No.)One Amgen Center Drive91320-1799Thousand OaksCalifornia(Address of principal executive offi

3、ces)(Zip Code)(805)447-1000(Registrants telephone number,including area code)Securities registered pursuant to Section 12(b)of the Act:Title of each classTrading Symbol(s)Name of each exchange on which registeredCommon stock,$0.0001 par valueAMGNThe Nasdaq Global Select Market2.00%Senior Notes due 2

4、026AMGN26The Nasdaq Global Select MarketSecurities registered pursuant to Section 12(g)of the Act:NoneIndicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes No Indicate by check mark if the registrant is not required to file reports

5、pursuant to Section 13 or Section 15(d)of the Act.Yes No Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or Section 15(d)of the Securities Exchange Actof 1934 during the preceding 12 months(or for such shorter period that the registrant was re

6、quired to file such reports),and(2)has been subject to such filingrequirements for the past 90 days.Yes No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 ofRegulation S-T(232.405 of this chapter)dur